Immunogen reported $330.42M in Current Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Agios Pharmaceuticals AGIO:US USD 784.94M 85.07M
Amgen AMGN:US USD 22.19B 1.88B
AstraZeneca AZN:LN USD 20.22B 693M
Bluebird Bio BLUE:US USD 160.44M 7.02M
Emergent Biosolutions EBS:US USD 1.12B 34.3M
Exelixis EXEL:US USD 1.84B 10.02M
Halozyme Therapeutics HALO:US USD 653.2M 111.26M
Heron Therapeutics HRTX:US USD 223.8M 29.6M
Immunogen IMGN:US USD 330.42M 63.51M
Intrexon XON:US USD 162.81M 1.81M
Karyopharm Therapeutics KPTI:US USD 222.68M 19.77M
Macrogenics MGNX:US USD 147.81M 19.82M
Nektar Therapeutics NKTR:US USD 599.48M 66.05M
Novartis NVS:US USD 36.91B 44M
Regeneron Pharmaceuticals REGN:US USD 22.06B 6.64B
Roche Holding ROG:VX 30.32B 5.31B
Seattle Genetics SGEN:US USD 2.76B 19.04M